Balchem Corporation (BCPC)

About Balchem Corporation

Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.

Company profile, industry and headcount are as reported by our data provider and can lag a company's own filings by a reporting period. The annual report is the authority.

Super investor ownership

11 of the funds we track reported a position in their latest SEC 13F filing. Largest first:

• Two Sigma, TWO SIGMA INVESTMENTS, LP$84.82M · 0.1% of book
• Jeremy Grantham, Grantham, Mayo, Van Otterloo & Co. LLC$36.68M · 0.1% of book
• Renaissance Technologies, RENAISSANCE TECHNOLOGIES LLC$32.66M · 0.0% of book
• Israel Englander, MILLENNIUM MANAGEMENT LLC$31.18M · 0.0% of book
• Marshall Wace, MARSHALL WACE, LLP$16.53M · 0.0% of book

A word of warning on reading these figures: a 13F reports the market value of a holding, so a fund that traded nothing at all still appears to have sold when the price fell. We found 102 companies where the standard reading gives the opposite answer. Only the share count is honest.

Politician trades in BCPC

We hold 6 disclosed trades in BCPC by members of Congress and executive-branch officials. The latest 5:

• Gilbert Cisneros · HouseBuy · $1,001 - $15,000 · traded 10 Jul 2026 · disclosed 4 Sept 2026
• Donald J Trump · Executive branchSell · $15,001 - $50,000 · traded 15 May 2026 · disclosed 1 Jul 2026
• Donald J Trump · Executive branchBuy · $15,001 - $50,000 · traded 30 Apr 2026 · disclosed 1 Jul 2026
• Donald J Trump · Executive branchSell · $50,001 - $100,000 · traded 29 Jul 2024 · disclosed 22 Sept 2026
• Gilbert Cisneros · HouseBuy · $1,001 - $15,000 · traded 21 May 2020 · disclosed 16 Jun 2020

A disclosure reports a value band, not an amount, and is due up to 45 days after the trade; some arrive later. Every filer we track, each with their own page, is on the Congress trading tracker.

Common questions